Online ISSN: 1945-4589
About Aging
Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways.

Systematic Analysis of the Prognostic Value and Immunological Function of LTBR in Cancer

Aging

January 23, 2024
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 1, entitled, “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.” continue reading »

Efficacy and Safety of EGFR-TKIs for Elderly Patients With NSCLC

Aging

January 18, 2024
In a new study, researchers investigated the effectiveness and safety of EGFR-tyrosine kinase inhibitors in elderly patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC). continue reading »

Aberrant RBMX Expression Relevant for Cancer Prognosis and Immunotherapy Response

Aging

January 17, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “Aberrant RBMX expression is relevant for cancer prognosis and immunotherapy response.” continue reading »

Effects of Resveratrol on Circadian Clock Gene Expression in Young and Older Human Cells

Aging

January 15, 2024
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 16, Issue 1, entitled, “Effects of resveratrol on in vitro circadian clock gene expression in young and older human adipose-derived progenitor cells.” continue reading »

Rooted in Chinese Medicine: Zicao’s Anti-Cancer Effects on Lung Cancer

Aging

January 11, 2024
In this new study, researchers investigated a plant used in traditional Chinese medicine and its anti-cancer effects in non-small cell lung cancer (NSCLC). continue reading »